Pharmafile Logo
Pharmafocus logo
Advanced Search

device

Showing 5 posts of 5 posts found.

parkinsons_device_passion_productions

British scientist develops technology able to deliver drugs directly into the brain

February 27, 2019
Research and Development device, medical technology, neurology, neuroscince, parkinson's cns

A British scientist has developed innovative technology that is able to deliver drugs deep into the brain in order to …

News

Prototype skin implant signals cancer by forming a visible mole

April 20, 2018
Medical Communications Cancer, device, implant, medtech, pharma

Researchers working with Professor Martin Fussenegger at the Department of Biosystems Science and Engineering at ETH Zurich in Basel have …

News
QELFA device

Novel device could help fight kidney disease

February 24, 2015
Research and Development, Sales and Marketing Bio Nano Consulting, Pfizer, QELFA, Rapamune, device, ime, kidney

A novel device that combines nanotechnology and a pregnancy tester could help treat kidney disease, according to a report by …

News
Chip image

Contraceptive microchip tipped to revolutionise birth control

July 14, 2014
Medical Communications, Sales and Marketing Bill Gates, MIT, contraceptive, device, implant, microchips

IT start-up company MicroCHIPS is developing a radical new contraceptive in the form of a microchip that is implanted under …

News
‘E-tattoo’ image

‘E-tattoo’ could help deliver drugs into patients

April 4, 2014
Medical Communications, Sales and Marketing device, digital, etattoo, nature, wearable tech

Researchers have created a new wearable device that is as thin as a temporary tattoo and can store and transmit …

News

Latest content

Ardena announces €20m expansion following first GMP approval

April 19, 2024

Roche’s Alecensa approved by FDA as lung cancer treatment

April 19, 2024

GSK shares results from phase 3 trial for gonorrhoea treatment

April 18, 2024

Eli Lilly’s tirzepatide demonstrates efficacy in reducing sleep apnoea severity

April 18, 2024

Medincell and AbbVie enter agreement for development of next-generation injectables

April 17, 2024